A patient in Washington, newly diagnosed with breast cancer, fought to get her lumpectomy surgery rescheduled after it […]

UK medicines agencies have changed their advice on ibuprofen to say that the drug can be used to […]

Bristol Myers Squibb’s Opdivo-Yervoy combo is awaiting some critical decisions in non-small cell lung cancer, but in the […]

For patients taking generic antibiotics, adequate potency levels can mean the difference between a quick recovery and a […]

For about two months, Alexion has been exploring whether its Soliris—used to treat several rare diseases—might hold promise in treating […]

As a partner with Novartis on JAK inhibitor Jakafi, Incyte has pinned its future fortunes on the success […]

As the U.S. economic toll from COVID-19 lockdowns continue to mount—with tens of millions out of work and businesses suffering—discussion has […]

As an ex-army surgeon and a military historian, we have previously felt uneasy about healthcare workers being described […]

Incyte’s Pemazyre can now be used to treat the bile duct cancer. The firm has also launched a […]

The agency concluded that the risks of the medicine outweigh its benefits